Jenn highlights the significant risks associated with breast cancer treatments, emphasizing that they can lead to increased chances of heart disease, brain degeneration, and osteoporosis. The conversation reveals the complexities of monitoring breast cancer, suggesting that waiting for clinical symptoms rather than relying solely on mammograms may be a more effective approach. The reality of aggressive cancer variants complicates early detection, raising important questions about treatment strategies.
